Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Diagnostics & prognostics

Disease Area Infectious diseases

The COVID-19 Pandemic: A Summary

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status

Tools & Techniques Diagnostics & prognostics

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Research Field Biomedical engineering

Fiber Fantastic

| Jonathan James

Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.

Disease Area Metabolism & Diabetes

IEM Identification

| Jonathan James

Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.

Tools & Techniques Diagnostics & prognostics

PREDICTive Power

| Jonathan James

Prostate cancer prognosis presents a challenge – but a new algorithmic tool may help personalize predictions

Tools & Techniques Diagnostics & prognostics

Unlocking Serology’s Secrets

| Jonathan James

We explore the work of researchers aiming to revolutionize the diagnosis of fibromyalgia and cholera using blood-based technologies.

Tools & Techniques Diagnostics & prognostics

Solving the Big Problems

| Luke Turner

We speak to bioengineer Stephen Quake to learn about the noninvasive prenatal tests that have saved thousands of pregnant women’s lives

Tools & Techniques Diagnostics & prognostics

An Inside Look at the CNS

| Danielle Fortuna, Mark Curtis

Neurological disorders can be invasive and time-consuming to diagnose, but profiling cytokines in the cerebrospinal fluid can lessen that burden

Tools & Techniques Diagnostics & prognostics

Seeing is Believing

| Jonathan James

Could changes in retinal blood vessels act as an early bio-marker for Alzheimer’s disease?

Tools & Techniques Diagnostics & prognostics

A Nose for Cancer

| Jonathan James

Could a multi-layer graphene (MLG)-based biomarker sensor offer the sensitivity needed for earlier lung cancer detection?


Sister Publications

You might be interested in our Sister Publications:

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register